GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

NCT01497665 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Slow recruitment

Conditions

Non-small Cell Lung Cancer (NSCLC) With Brain Metastases

Interventions

DRUG: GRN1005

Sponsor

Angiochem Inc